SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001659617-20-000132
Filing Date
2020-05-15
Accepted
2020-05-15 16:00:05
Documents
1
Effectiveness Date
2020-05-15

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14a-proxyadjourn2020.htm DEFA14A 26450
  Complete submission text file 0001659617-20-000132.txt   27465
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

IRS No.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37758 | Film No.: 20884722
SIC: 2834 Pharmaceutical Preparations